
Emilio Torres at IV CONGRESO CÓRNEA COLOMBIA 2025
The Congreso Córnea Colombia provided an important platform for scientific exchange, and the warm hospitality of the Colombian community made the experience particularly meaningful. ELZA

The Congreso Córnea Colombia provided an important platform for scientific exchange, and the warm hospitality of the Colombian community made the experience particularly meaningful. ELZA

From 12–15 September 2025, the ELZA team will be at the ESCRS Annual Meeting in Copenhagen. Learn more…

At the Polish Ophthalmologists Congress, Prof. Farhad Hafezi presented innovative keratoconus treatments ELZA-PACE and ECO-CAIRS in Krakow.

Dr. Emilio Torres-Netto presented ELZA-PACE cross-linking at BRASCRS 2025, a customised, tissue-preserving keratoconus vision rehabilitation method with promising clinical outcomes.

ECO-CAIRS extends tissue-based keratoconus surgery by optimizing allogenic ring segments through extracorporeal cross-linking.

At EgSCRS, ELZA’s pyramid approach to keratoconus: ELZA-sub400, PACE, ECO-CAIRS, and AI-guided diagnostics was presented in detail.

During this visit to TOS 2025, Prof. Hafezi presented ECO-CAIRS and ELZA-PACE and highlighted the Light for Sight Foundation’s work to improve care for children with Down Syndrome.

Ocular Surgery News interviewed Prof. Farhad Hafezi at ESCRS 2025 on ECO-CAIRS, a technique using ultra high-fluence corneal cross-linking (CXL) to optimize allogenic corneal ring segments before implantation, improving precision and biomechanical stability.

At the ESCRS Winter Meeting 2025, Prof. Farhad Hafezi and Dr. Emilio Torres-Netto presented research on corneal cross-linking (CXL), including high-fluence protocols, keratoconus management, and biomechanical assessments.

Prof. Hafezi presents Femto-CAIRS and high fluence cross-linking, highlighting its advantages for keratoconus treatment and improving visual outcomes
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.